Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2016 May 3;6:25342. doi: 10.1038/srep25342

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2016, Macmillan Publishers Limited

This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

PMC Copyright notice

(A,B) Immunoblot showing the levels of P-ERK1/2^T202/Y204, P-RSK^T359/S363, P-eNOS^S1177, P-nNOS^S1416, and iNOS after treatment with resveratrol and compound C. (P-ERK1/2^T202/Y204, P-RSK^T359/S363, P-nNOS^S1416, P-eNOS^S1177, iNOS and actin the position of the 44/42, 90, 165, 140, 130 and 43-kDa molecular weight marker is indicated, respectively) The elevated ERK1/2, RSK, and nNOS phosphorylation ratios after treatment with resveratrol were reduced by compound C in the RVLM. The values shown are the means ± SEM, n = 6. *P < 0.05, **P < 0.01.